Literature DB >> 14559223

Introduction of short interfering RNA to silence endogenous E-selectin in vascular endothelium leads to successful inhibition of leukocyte adhesion.

Yasunobu Nishiwaki1, Takanori Yokota, Megumi Hiraoka, Makoto Miyagishi, Kazunari Taira, Mitsuaki Isobe, Hidehiro Mizusawa, Masayuki Yoshida.   

Abstract

Short interfering RNAs (siRNAs) are powerful sequence-specific reagents that suppress gene expression in mammalian cells. We report for the first time that gene silencing of endothelial E-selectin by siRNAs leads to successful inhibition of leukocyte-endothelial interaction under flow. siRNAs designed to target human E-selectin were tranfected into human umbilical vein endothelial cells (HUVEC). Western blotting analysis revealed that transfection of these siRNAs, but not the scrambled control siRNA (100nM each), attenuated E-selectin expression in HUVEC activated with TNF-alpha (10ng/ml, 4h) without affecting expression of ICAM-1. Moreover, a leukocyte adhesion assay under flow (shear stress=1.0dyne/cm(2)) demonstrated that HUVEC transfected with a siRNA against E-selectin (siE-01) supported significantly less HL60 adhesion as compared to those transfected with the control siRNA (scE-01) after activation (p<0.03). This technique provides a powerful strategy to dissect a specific function of a given molecule in leukocyte-endothelial interaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559223     DOI: 10.1016/j.bbrc.2003.09.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

2.  Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin.

Authors:  Shunsuke Ito; Mizuko Osaka; Yusuke Higuchi; Fuyuhiko Nishijima; Hideto Ishii; Masayuki Yoshida
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

3.  RNA interference as a potential therapeutic treatment for inflammation associated lung injury.

Authors:  Joanne Lomas-Neira; Chun-Shiang Chung; Alfred Ayala
Journal:  Int J Clin Exp Med       Date:  2008-02-25

4.  Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery.

Authors:  Ian J Welsby; Mihai V Podgoreanu; Barbara Phillips-Bute; Richard Morris; Joseph P Mathew; Peter K Smith; Mark F Newman; Debra A Schwinn; Mark Stafford-Smith
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-01-06       Impact factor: 2.628

5.  HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells.

Authors:  Smarajit Bandyopadhyay; Mohammad Z Ashraf; Pamela Daher; Philip H Howe; Paul E DiCorleto
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

6.  MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation.

Authors:  Magdalena M Gorska; Qiaoling Liang; Susan J Stafford; Nicolas Goplen; Nilesh Dharajiya; Lei Guo; Sanjiv Sur; Matthias Gaestel; Rafeul Alam
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

Review 7.  RNA interference: a potent tool for gene-specific therapeutics.

Authors:  Thomas E Ichim; Mu Li; Hua Qian; Igor A Popov; Katarzyna Rycerz; Xiufen Zheng; David White; Robert Zhong; Wei-Ping Min
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.